Hematological Malignancies Disease Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Table of Content

1 Industry Overview

• 1.1 Hematological Malignancies Disease Industry

Figure Hematological Malignancies Disease Industry Chain Structure

• 1.1.1 Overview
• 1.1.2 Development of Hematological Malignancies Disease

Table Upstream Segment of Hematological Malignancies Disease

• 1.2.2 Downstream

Table Application Segment of Hematological Malignancies Disease

Table Global Hematological Malignancies Disease Market 2015-2025, by Application, in USD Million

• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Hematological Malignancies Disease Market by Type

• 3.1 By Type
  • 3.1.1 Chemotherapy

Table Major Company List of Chemotherapy

• 3.1.2 Immunotherapy

Table Major Company List of Immunotherapy

• 3.1.3 Targeted Therapy

Table Major Company List of Targeted Therapy

• 3.2 Market Size

Table Global Hematological Malignancies Disease Market 2015-2019, by Type, in USD Million

Figure Global Hematological Malignancies Disease Market Growth 2015-2019, by Type, in USD Million

Table Global Hematological Malignancies Disease Market 2015-2019, by Type, in Volume

Figure Global Hematological Malignancies Disease Market Growth 2015-2019, by Type, in Volume

• 3.3 Market Forecast

Table Global Hematological Malignancies Disease Market Forecast 2020-2025, by Type, in USD Million

Table Global Hematological Malignancies Disease Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

• 4.1 Affymetrix (Company Profile, Sales Data etc.)
  • 4.1.1 Affymetrix Profile

Table Affymetrix Overview List

• 4.1.2 Affymetrix Products & Services
• 4.1.3 Affymetrix Business Operation Conditions

Table Business Operation of Affymetrix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.2 SkylineDx (Company Profile, Sales Data etc.)
  • 4.2.1 SkylineDx Profile

Table SkylineDx Overview List

• 4.2.2 SkylineDx Products & Services
• 4.2.3 SkylineDx Business Operation Conditions

Table Business Operation of SkylineDx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.3 AgenaBio (Company Profile, Sales Data etc.)
  • 4.3.1 AgenaBio Profile

Table AgenaBio Overview List

• 4.3.2 AgenaBio Products & Services
• 4.3.3 AgenaBio Business Operation Conditions

Table Business Operation of AgenaBio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.4 Signal Genetics (Company Profile, Sales Data etc.)
  • 4.4.1 Signal Genetics Profile

Table Signal Genetics Overview List

• 4.4.2 Signal Genetics Products & Services
• 4.4.3 Signal Genetics Business Operation Conditions

Table Business Operation of Signal Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.5 Cancer Genetics Inc (Company Profile, Sales Data etc.)
  • 4.5.1 Cancer Genetics Inc Profile

Table Cancer Genetics Inc Overview List

• 4.5.2 Cancer Genetics Inc Products & Services
• 4.5.3 Cancer Genetics Inc Business Operation Conditions

Table Business Operation of Cancer Genetics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.6 Illumina (Company Profile, Sales Data etc.)
  • 4.6.1 Illumina Profile

Table Illumina Overview List

• 4.6.2 Illumina Products & Services
• 4.6.3 Illumina Business Operation Conditions

Table Business Operation of Illumina (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.7 NeoGenomics (Company Profile, Sales Data etc.)
  • 4.7.1 NeoGenomics Profile

Table NeoGenomics Overview List

• 4.7.2 NeoGenomics Products & Services
• 4.7.3 NeoGenomics Business Operation Conditions

Table Business Operation of NeoGenomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.8 Exiqon (Company Profile, Sales Data etc.)
  • 4.8.1 Exiqon Profile

Table Exiqon Overview List

• 4.8.2 Exiqon Products & Services
• 4.8.3 Exiqon Business Operation Conditions

Table Business Operation of Exiqon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.9 Regulus Therapeutics (Company Profile, Sales Data etc.)
  • 4.9.1 Regulus Therapeutics Profile

Table Regulus Therapeutics Overview List

• 4.9.2 Regulus Therapeutics Products & Services
• 4.9.3 Regulus Therapeutics Business Operation Conditions

Table Business Operation of Regulus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.10 Rosetta Genomics (Company Profile, Sales Data etc.)
  • 4.10.1 Rosetta Genomics Profile

Table Rosetta Genomics Overview List

• 4.10.2 Rosetta Genomics Products & Services
• 4.10.3 Rosetta Genomics Business Operation Conditions

Table Business Operation of Rosetta Genomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.11 Sequenta (Company Profile, Sales Data etc.)
  • 4.11.1 Sequenta Profile

Table Sequenta Overview List

• 4.11.2 Sequenta Products & Services
• 4.11.3 Sequenta Business Operation Conditions

Table Business Operation of Sequenta (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.12 Takeda Pharma (Company Profile, Sales Data etc.)
  • 4.12.1 Takeda Pharma Profile

Table Takeda Pharma Overview List

• 4.12.2 Takeda Pharma Products & Services
• 4.12.3 Takeda Pharma Business Operation Conditions

Table Business Operation of Takeda Pharma (Sales Revenue, Cost, Gross Margin)

• 4.13 Celgene (Company Profile, Sales Data etc.)
  • 4.13.1 Celgene Profile

Table Celgene Overview List

• 4.13.2 Celgene Products & Services
• 4.13.3 Celgene Business Operation Conditions

Table Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.14 Amgen (Company Profile, Sales Data etc.)
  • 4.14.1 Amgen Profile

Table Amgen Overview List

• 4.14.2 Amgen Products & Services
• 4.14.3 Amgen Business Operation Conditions

Table Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)

• 4.15 Ono Pharma (Company Profile, Sales Data etc.)
  • 4.15.1 Ono Pharma Profile

Table Ono Pharma Overview List

• 4.15.2 Ono Pharma Products & Services
• 4.15.3 Ono Pharma Business Operation Conditions

Table Business Operation of Ono Pharma (Sales Revenue, Cost, Gross Margin)

• 4.16 Abbott (Company Profile, Sales Data etc.)
  • 4.16.1 Abbott Profile

Table Abbott Overview List

• 4.16.2 Abbott Products & Services
• 4.16.3 Abbott Business Operation Conditions

Table Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)

• 4.17 BMS (Company Profile, Sales Data etc.)
  • 4.17.1 BMS Profile

Table BMS Overview List

• 4.17.2 BMS Products & Services
• 4.17.3 BMS Business Operation Conditions

Table Business Operation of BMS (Sales Revenue, Cost, Gross Margin)

• 4.18 Mundipharma (Company Profile, Sales Data etc.)
  • 4.18.1 Mundipharma Profile

Table Mundipharma Overview List

• 4.18.2 Mundipharma Products & Services
• 4.18.3 Mundipharma Business Operation Conditions

Table Business Operation of Mundipharma (Sales Revenue, Cost, Gross Margin)

• 4.19 Novartis (Company Profile, Sales Data etc.)
  • 4.19.1 Novartis Profile

Table Novartis Overview List

• 4.19.2 Novartis Products & Services
• 4.19.3 Novartis Business Operation Conditions

Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)

• 4.20 MorphoSys (Company Profile, Sales Data etc.)
  • 4.20.1 MorphoSys Profile

Table MorphoSys Overview List

• 4.20.2 MorphoSys Products & Services
• 4.20.3 MorphoSys Business Operation Conditions

Table Business Operation of MorphoSys (Sales Revenue, Cost, Gross Margin)

5 Market Competition

• 5.1 Company Competition

Table Global Hematological Malignancies Disease Sales Revenue 2015-2019, by Company, in USD Million

Table Global Hematological Malignancies Disease Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Hematological Malignancies Disease Sales Revenue Share in 2019, by Company, in USD Million

Table Global Hematological Malignancies Disease Sales Volume 2015-2019, by Company, in Volume

Table Global Hematological Malignancies Disease Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Hematological Malignancies Disease Sales Volume Share in 2019, by Company, in Volume

• 5.2 Regional Market by Company

Figure North America Hematological Malignancies Disease Market Concentration, in 2019

Figure Europe Hematological Malignancies Disease Market Market Concentration, in 2019

Figure Asia-Pacific Hematological Malignancies Disease MMarket Concentration, in 2019

Figure South America Hematological Malignancies Disease Market Concentration, in 2019

Figure Middle East & Africa Hematological Malignancies Disease Market Concentration, in 2019

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Leukemia

Figure Hematological Malignancies Disease Demand in Leukemia , 2015-2019, in USD Million

Figure Hematological Malignancies Disease Demand in Leukemia , 2015-2019, in Volume

• 6.1.2 Demand in Lymphoma

Figure Hematological Malignancies Disease Demand in Lymphoma , 2015-2019, in USD Million

Figure Hematological Malignancies Disease Demand in Lymphoma , 2015-2019, in Volume

• 6.1.3 Demand in Myeloma

Figure Hematological Malignancies Disease Demand in Myeloma, 2015-2019, in USD Million

Figure Hematological Malignancies Disease Demand in Myeloma, 2015-2019, in Volume

• 6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

• 6.3 Demand Forecast

Table Hematological Malignancies Disease Demand Forecast 2020-2025, by Application, in USD Million

Figure Hematological Malignancies Disease Market Growth 2020-2025, by Application, in USD Million

Figure Hematological Malignancies Disease Market Share in 2025, by Application, in USD Million

Table Hematological Malignancies Disease Demand Forecast 2020-2025, by Application, in Volume

Table Hematological Malignancies Disease Market Growth 2020-2025, by Application, in Volume

Table Hematological Malignancies Disease Market Share in 2025, by Application, in Volume

7 Region Operation

• 7.1 Regional Production

Table Hematological Malignancies Disease Production 2015-2019, by Region, in USD Million

Table Hematological Malignancies Disease Production 2015-2019, by Region, in Volume

• 7.2 Regional Market

Table Global Hematological Malignancies Disease Market 2015-2019, by Region, in USD Million

Table Global Hematological Malignancies Disease Market Share 2015-2019, by Region, in USD Million

Table Global Hematological Malignancies Disease Market 2015-2019, by Region, in Volume

Table Global Hematological Malignancies Disease Market Share 2015-2019, by Region, in Volume

• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview

  Figure North America Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

  Figure North America Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

  • 7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table North America Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

• 7.3.2 Europe
  • 7.3.2.1 Overview

Figure Europe Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure Europe Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

• 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table Europe Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

• 7.3.3 Asia-Pacific
  • 7.3.3.1 Overview

Figure Asia-Pacific Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

• 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

• 7.3.4 South America
  • 7.3.4.1 Overview

Figure South America Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure South America Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

• 7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table South America Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

• 7.3.5 Middle East & Africa
  • 7.3.5.1 Overview

Figure Middle East & Africa Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

• 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

• 7.4 Regional Import & Export
• 7.5 Regional Forecast

Table Hematological Malignancies Disease Market Forecast 2020-2025, by Region, in USD Million

Table Hematological Malignancies Disease Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change

Table Price Factors List

• 8.1.3 Manufacturers Gross Margin Analysis

Figure Marketing Channels Overview

9 Research Conclusion

List of Tables

List of Table

List of Table

Table Upstream Segment of Hematological Malignancies Disease

Table Application Segment of Hematological Malignancies Disease

Table Global Hematological Malignancies Disease Market 2015-2025, by Application, in USD Million

Table Major Company List of Immunotherapy

Table Major Company List of Targeted Therapy

Table Global Hematological Malignancies Disease Market 2015-2019, by Type, in USD Million

Table Global Hematological Malignancies Disease Market 2015-2019, by Type, in Volume

Table Global Hematological Malignancies Disease Market Forecast 2020-2025, by Type, in USD Million

Table Global Hematological Malignancies Disease Market Forecast 2020-2025, by Type, in Volume

Table Affymetrix Overview List

Table Business Operation of Affymetrix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table SkylineDx Overview List

Table Business Operation of SkylineDx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AgenaBio Overview List

Table Business Operation of AgenaBio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Signal Genetics Overview List

Table Business Operation of Signal Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cancer Genetics Inc Overview List

Table Business Operation of Cancer Genetics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Illumina Overview List

Table Business Operation of Illumina (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table NeoGenomics Overview List

Table Business Operation of NeoGenomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Exiqon Overview List

Table Business Operation of Exiqon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Regulus Therapeutics Overview List

Table Business Operation of Regulus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Rosetta Genomics Overview List

Table Business Operation of Rosetta Genomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sequenta Overview List

Table Business Operation of Sequenta (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Pharma Overview List

Table Business Operation of Takeda Pharma (Sales Revenue, Cost, Gross Margin)

Table Celgene Overview List

Table Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)

Table Ono Pharma Overview List

Table Business Operation of Ono Pharma (Sales Revenue, Cost, Gross Margin)

Table Abbott Overview List

Table Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)

Table BMS Overview List

Table Business Operation of BMS (Sales Revenue, Cost, Gross Margin)

Table Mundipharma Overview List

Table Business Operation of Mundipharma (Sales Revenue, Cost, Gross Margin)

Table Novartis Overview List

Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)

Table MorphoSys Overview List

Table Business Operation of MorphoSys (Sales Revenue, Cost, Gross Margin)

Table Global Hematological Malignancies Disease Sales Revenue 2015-2019, by Company, in USD Million

Table Global Hematological Malignancies Disease Sales Revenue Share 2015-2019, by Company, in USD Million

Table Global Hematological Malignancies Disease Sales Volume 2015-2019, by Company, in Volume

Table Global Hematological Malignancies Disease Sales Volume Share 2015-2019, by Company, in Volume

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Hematological Malignancies Disease Demand Forecast 2020-2025, by Application, in USD Million

Table Hematological Malignancies Disease Demand Forecast 2020-2025, by Application, in Volume

Table Hematological Malignancies Disease Market Growth 2020-2025, by Application, in Volume

Table Hematological Malignancies Disease Market Share in 2025, by Application, in Volume

Table Hematological Malignancies Disease Production 2015-2019, by Region, in USD Million

Table Hematological Malignancies Disease Production 2015-2019, by Region, in Volume

Table Global Hematological Malignancies Disease Market 2015-2019, by Region, in USD Million

Table Global Hematological Malignancies Disease Market Share 2015-2019, by Region, in USD Million

Table Global Hematological Malignancies Disease Market 2015-2019, by Region, in Volume

Table Global Hematological Malignancies Disease Market Share 2015-2019, by Region, in Volume

Table North America Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table North America Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

Table Europe Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table Europe Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

Table Asia-Pacific Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

Table South America Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table South America Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

Table Middle East & Africa Hematological Malignancies Disease Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Hematological Malignancies Disease Market Size 2015-2019, by Country, in Volume

Table Hematological Malignancies Disease Market Forecast 2020-2025, by Region, in USD Million

Table Hematological Malignancies Disease Market Forecast 2020-2025, by Region, in Volume

Table Price Factors List

List of Figures

List of Figure

Figure Hematological Malignancies Disease Industry Chain Structure

Figure Global Hematological Malignancies Disease Market Growth 2015-2019, by Type, in USD Million

Figure Global Hematological Malignancies Disease Market Growth 2015-2019, by Type, in Volume

Figure Global Hematological Malignancies Disease Sales Revenue Share in 2019, by Company, in USD Million

Figure Global Hematological Malignancies Disease Sales Volume Share in 2019, by Company, in Volume

Figure North America Hematological Malignancies Disease Market Concentration, in 2019

Figure Europe Hematological Malignancies Disease Market Market Concentration, in 2019

Figure Asia-Pacific Hematological Malignancies Disease MMarket Concentration, in 2019

Figure South America Hematological Malignancies Disease Market Concentration, in 2019

Figure Middle East & Africa Hematological Malignancies Disease Market Concentration, in 2019

Figure Hematological Malignancies Disease Demand in Leukemia , 2015-2019, in USD Million

Figure Hematological Malignancies Disease Demand in Leukemia , 2015-2019, in Volume

Figure Hematological Malignancies Disease Demand in Lymphoma , 2015-2019, in USD Million

Figure Hematological Malignancies Disease Demand in Lymphoma , 2015-2019, in Volume

Figure Hematological Malignancies Disease Demand in Myeloma, 2015-2019, in USD Million

Figure Hematological Malignancies Disease Demand in Myeloma, 2015-2019, in Volume

Figure Hematological Malignancies Disease Market Growth 2020-2025, by Application, in USD Million

Figure Hematological Malignancies Disease Market Share in 2025, by Application, in USD Million

Figure North America Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure North America Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

Figure Europe Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure Europe Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

Figure Asia-Pacific Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

Figure South America Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure South America Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

Figure Middle East & Africa Hematological Malignancies Disease Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Hematological Malignancies Disease Market Size and Growth 2015-2019, in Volume

Figure Marketing Channels Overview